Natixis’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $41.5M | Hold |
|
|||||
|
2025
Q1 | $40.3M | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $249 | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $111M | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $155M | Hold |
|
|||||
|
2019
Q4 | $190M | Buy |
|
|||||
|
2019
Q3 | $3.02M | Buy |
|
|||||
|
2019
Q2 | $2.69M | Sell |
|
|||||
|
2019
Q1 | $2.83M | Sell |
|
|||||
|
2018
Q4 | $5.08M | Buy |
|
|||||
|
2018
Q3 | $3.86M | Sell |
|
|||||
|
2018
Q2 | $4.71M | Buy |
|
|||||
|
2018
Q1 | $4.12M | Buy |
|
|||||
|
2017
Q4 | $2.72M | Buy |
|
|||||
|
2017
Q3 | $1.98M | Sell |
|
|||||
|
2017
Q2 | $27M | Buy |
|
|||||
|
2017
Q1 | $8.65M | Buy |
|
|||||
|
2016
Q4 | $4.93M | Buy |
|
|||||
|
2016
Q3 | $3.95M | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $521K | Buy |
|
|||||
|
2015
Q2 | $499K | Buy |
|